Skip to main content
. 2024 Dec 11;15:1515030. doi: 10.3389/fphar.2024.1515030

TABLE 1.

Differences in NO treatment and Clinical outcomes after PSM.

Characteristic BPD grade Ⅰ N = 46 a BPD grade Ⅱ-Ⅲ, N = 31 a p-value
Date of iNO Initiation (hours) 16 (7, 26) 14 (8, 45) 0.893 b
Date of iNO Initiation≤168 h (7 days) 45 (97.8%) 25 (80.6%) 0.015 b
Initial iNO Dose (ppm) 13.0 (8.3, 20.0) 8.0 (5.0, 10.0) <0.001 b
Maximum iNO Dose (ppm) 15.0 (8.3, 20.0) 10.0 (5.0, 15.0) 0.040 b
Initial iNO Dose/BW 10.3 (5.4, 14.5) 5.7 (3.2, 10.1) 0.004 b
Maximum iNO Dose/BW 11 (6, 15) 7 (4, 12) 0.059 b
Duration of iNO Therapy (hours) 57 (38, 87) 56 (27, 111) 0.975 b
Total Mechanical Ventilation 6 (4, 11) 7 (4, 22) 0.211 b
Total High Frequency Ventilation Time 2.0 (1.0, 4.8) 5.0 (2.0, 7.0) 0.026 b
Total Conventional Mechanical Ventilation 4 (1, 6) 2 (1, 12) 0.642 b
Total Non-invasive Ventilation Time 19 (10, 28) 26 (11, 35) 0.113 b
Total Oxygenation Time 38 (24, 58) 57 (43, 69) 0.002 b
Platelet Count (10^9/L) 153 ± 75 149 ± 68 0.795 b
Prothrombin Time (s) 17 (3, 19) 15 (13, 18) 0.783 b
Fibrinogen Level (g/L) 1.90 (1.40, 2.16) 2.04 (1.63, 2.30) 0.149 b
Activated Partial Thromboplastin Time 71 (66, 76) 68 (58, 79) 0.458 b
Pre-treatment SpO2 (3 h prior) 7.8 (6.0, 10.9) 8.3 (6.6, 10.0) 0.747 b
Post-treatment SpO2 (3 h after) 10 (4, 12) 10 (8, 12) 0.728 b
SpO2 Difference (3 h) −2.00 (−2.00, −1.00) −2.00 (−2.00, −1.00) 0.269 b
Oxygenation Index (3 h) 10 (9, 13) 10 (9, 12) 0.228 b
P/F Ratio (3 h) 155 (102, 180) 154 (125, 179) 0.880 b
Oxygenation Index (24 h) 7.7 (5.0, 11.2) 7.6 (4.7, 11.7) 0.839 b
P/F Ratio (24 h) 178 (110, 219) 176 (128, 239) 0.751 b
Oxygenation Index (48 h) 7.8 ± 4.2 8.4 ± 3.7 0.492 c
P/F Ratio (48 h) 184 (143, 240) 164 (114, 213) 0.220 d

Note:

a

Median (Interquartile Range); Mean ± Standard Deviation.

b

Wilcoxon.

c

t-test.

d

Wilcoxon rank sum exact test.